Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/ANI Pharmaceuticals, Inc./ SCHEDULE 13G/A

SEC Filing · SCHEDULE 13G/A

ANI Pharmaceuticals, Inc.

ANIPNASDAQEQUITYCurrent

SEC Filing

Filed Jul 27, 2026Accepted Jul 27, 2026, 4:25 PM EDTCIK 1023024Accession 0002012383-26-002156
View company →Permanent SEC source ↗
Share

Company context

Current securities

ANIPNASDAQ · EQUITY · Current

Recent company filings

  1. 144 filingSep 15, 2026
  2. 144 filingSep 11, 2026
  3. 4 filingAug 27, 2026
  4. 144 filingAug 25, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 24, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗